tiprankstipranks
Advertisement
Advertisement

AU:DXB Stock Latest News

Dimerix highlights kidney disease pipeline and diversification strategy at Bioshares Summit
Company AnnouncementsDimerix highlights kidney disease pipeline and diversification strategy at Bioshares Summit
11h ago
DXB
Dimerix to Highlight Kidney Disease Pipeline Progress at TechKnow Invest Conference
PremiumCompany Announcements
Dimerix to Highlight Kidney Disease Pipeline Progress at TechKnow Invest Conference
10d ago
DXB
Dimerix Secures Long-Term U.S. Patent Protection for Phase 2 Kidney Drug DMX-652
PremiumCompany Announcements
Dimerix Secures Long-Term U.S. Patent Protection for Phase 2 Kidney Drug DMX-652
14d ago
DXB
Dimerix Strikes Major Asian Licensing Deal for Phase 3 Kidney Drug DMX-200
PremiumCompany Announcements
Dimerix Strikes Major Asian Licensing Deal for Phase 3 Kidney Drug DMX-200
2M ago
DXB
Dimerix Highlights ACTION3 Trial De-Risking and Commercial Potential for DMX-200
PremiumCompany Announcements
Dimerix Highlights ACTION3 Trial De-Risking and Commercial Potential for DMX-200
3M ago
DXB
Dimerix Confirms Strong Statistical Power and Refines Strategy for Phase 3 FSGS Trial
PremiumCompany AnnouncementsDimerix Confirms Strong Statistical Power and Refines Strategy for Phase 3 FSGS Trial
3M ago
DXB
Dimerix to Court Singapore Investors With Update on Phase 3 Kidney Drug
Premium
Company Announcements
Dimerix to Court Singapore Investors With Update on Phase 3 Kidney Drug
4M ago
DXB
Dimerix Over-Recruits in Pivotal FSGS Phase 3 Trial as Last Adult Patient Dosed
Premium
Company Announcements
Dimerix Over-Recruits in Pivotal FSGS Phase 3 Trial as Last Adult Patient Dosed
5M ago
DXB
Dimerix Courts Investors With Perth and Singapore Briefings on FSGS Phase 3 Program
PremiumCompany Announcements
Dimerix Courts Investors With Perth and Singapore Briefings on FSGS Phase 3 Program
5M ago
DXB
Dimerix to Showcase Phase 3 FSGS Program at Oppenheimer Healthcare Conference
PremiumCompany Announcements
Dimerix to Showcase Phase 3 FSGS Program at Oppenheimer Healthcare Conference
5M ago
DXB
Dimerix Revenue Surges but Loss Deepens and Asset Base Thins
PremiumCompany Announcements
Dimerix Revenue Surges but Loss Deepens and Asset Base Thins
5M ago
DXB
Dimerix to Showcase Phase 3 FSGS Program and Growth Strategy at Euroz Hartleys Healthcare Forum
PremiumCompany Announcements
Dimerix to Showcase Phase 3 FSGS Program and Growth Strategy at Euroz Hartleys Healthcare Forum
6M ago
DXB
Dimerix Hits Phase 3 Recruitment Target for Lead Kidney Drug as FDA Backs Approval Pathway
PremiumCompany AnnouncementsDimerix Hits Phase 3 Recruitment Target for Lead Kidney Drug as FDA Backs Approval Pathway
6M ago
DXB
Dimerix Strengthens Leadership with Appointment of New CFO and Company Secretary
Premium
Company Announcements
Dimerix Strengthens Leadership with Appointment of New CFO and Company Secretary
7M ago
DXB
Dimerix Targets Investor and Partner Engagement at J.P. Morgan Healthcare Conference
Premium
Company Announcements
Dimerix Targets Investor and Partner Engagement at J.P. Morgan Healthcare Conference
7M ago
DXB
Dimerix Gains FDA Endorsement of Key Endpoint for Phase 3 FSGS Trial
PremiumCompany Announcements
Dimerix Gains FDA Endorsement of Key Endpoint for Phase 3 FSGS Trial
8M ago
DXB
BioMarin’s US$4.8bn Amicus Deal Preserves Dimerix Licensing Rights and Bolsters Rare Kidney Drug Outlook
PremiumCompany Announcements
BioMarin’s US$4.8bn Amicus Deal Preserves Dimerix Licensing Rights and Bolsters Rare Kidney Drug Outlook
8M ago
DXB
Dimerix Completes Recruitment for ACTION3 Phase 3 Trial
PremiumCompany Announcements
Dimerix Completes Recruitment for ACTION3 Phase 3 Trial
8M ago
DXB
Dimerix Limited Announces Director’s Interest Change
PremiumCompany Announcements
Dimerix Limited Announces Director’s Interest Change
8M ago
DXB
Dimerix Limited Issues Unquoted Securities for Employee Incentive
PremiumCompany AnnouncementsDimerix Limited Issues Unquoted Securities for Employee Incentive
8M ago
DXB
Dimerix Achieves Positive IDMC Review for Phase 3 FSGS Trial
Premium
Company Announcements
Dimerix Achieves Positive IDMC Review for Phase 3 FSGS Trial
9M ago
DXB
Dimerix Limited Successfully Passes All Resolutions at 2025 AGM
Premium
Company Announcements
Dimerix Limited Successfully Passes All Resolutions at 2025 AGM
9M ago
DXB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >